- Home
- CXDO vs LYEL Comparison
CXDO vs LYEL Comparison
Compare CXDO & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- LYEL
- Stock Information
- Founded
- CXDO 1995
- LYEL 2018
- Country
- CXDO United States
- LYEL United States
- Employees
- CXDO N/A
- LYEL N/A
- Industry
- CXDO Telecommunications Equipment
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- CXDO Telecommunications
- LYEL Health Care
- Exchange
- CXDO Nasdaq
- LYEL Nasdaq
- Market Cap
- CXDO 194.0M
- LYEL 207.7M
- IPO Year
- CXDO 1998
- LYEL 2021
- Fundamental
- Price
- CXDO $4.98
- LYEL $0.48
- Analyst Decision
- CXDO Strong Buy
- LYEL Sell
- Analyst Count
- CXDO 2
- LYEL 2
- Target Price
- CXDO $8.75
- LYEL $1.00
- AVG Volume (30 Days)
- CXDO 281.0K
- LYEL 828.6K
- Earning Date
- CXDO 03-04-2025
- LYEL 03-11-2025
- Dividend Yield
- CXDO N/A
- LYEL N/A
- EPS Growth
- CXDO N/A
- LYEL N/A
- EPS
- CXDO 0.06
- LYEL N/A
- Revenue
- CXDO $60,838,000.00
- LYEL $61,000.00
- Revenue This Year
- CXDO $12.19
- LYEL N/A
- Revenue Next Year
- CXDO $12.65
- LYEL N/A
- P/E Ratio
- CXDO $83.67
- LYEL N/A
- Revenue Growth
- CXDO 14.36
- LYEL N/A
- 52 Week Low
- CXDO $2.92
- LYEL $0.48
- 52 Week High
- CXDO $7.34
- LYEL $3.15
- Technical
- Relative Strength Index (RSI)
- CXDO 36.74
- LYEL 38.70
- Support Level
- CXDO $5.24
- LYEL $0.53
- Resistance Level
- CXDO $5.80
- LYEL $0.63
- Average True Range (ATR)
- CXDO 0.32
- LYEL 0.07
- MACD
- CXDO -0.10
- LYEL -0.01
- Stochastic Oscillator
- CXDO 13.53
- LYEL 1.69
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of revenue from the Cloud telecommunications segment.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.